Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Worms

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Behavioural Pharmacology|February 1, 1994
Social olfactory recognition in rodents: deterioration with age, cerebral ischaemia and septal lesionJ.P. Terranova, A. Pério, P. Worms, et al.
European Journal of Pharmacology|July 2, 1987
Effects of intracerebroventricular pirenzepine on muscarinic discriminations in ratsM Jung, A Perio, J P Terranova, et al.
Journal of Neural Transmission. Supplementum|January 1, 1983
Pharmacological and therapeutic actions of GABA receptor agonistsB Zivkovic, B Scatton, P Worms, et al.
Advances in Biochemical Psychopharmacology|January 1, 1981
Interactions between GABA, dopamine, acetylcholine, and glutamate-containing neurons in the extrapyramidal and limbic systemsG Bartholini, B Scatton, P Worms, et al.
European Journal of Pharmacology|July 11, 1985
The effect of different types of cortical lesions on drug-induced catalepsy in rats: a pharmacological analysisP Worms, M T Willigens, D Continsouza-Blanc, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1987
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodentsP Worms, J P Kan, C G Wermuth, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1987
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibitionJ P Kan, R Steinberg, C Mouget-Goniot, et al.
Progress in Clinical and Biological Research|January 1, 1983
Indications for the use of gamma-aminobutyric acid (GABA)-agonists in convulsant disordersK G Lloyd, C Munari, P Worms, et al.
Advances in Biochemical Psychopharmacology|January 1, 1983
Neurochemical and neuropharmacological indications for the involvement of GABA and glycine receptors in neuropsychiatric disordersK G Lloyd, G DeMontis, C L Broekkamp, et al.
Drugs Under Experimental and Clinical Research|January 1, 1985
Minaprine, a new drug with antidepressant propertiesK Bizière, P Worms, J P Kan, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Behavioural Pharmacology|February 1, 1994
Social olfactory recognition in rodents: deterioration with age, cerebral ischaemia and septal lesionJ.P. Terranova, A. Pério, P. Worms, et al.
European Journal of Pharmacology|July 2, 1987
Effects of intracerebroventricular pirenzepine on muscarinic discriminations in ratsM Jung, A Perio, J P Terranova, et al.
Journal of Neural Transmission. Supplementum|January 1, 1983
Pharmacological and therapeutic actions of GABA receptor agonistsB Zivkovic, B Scatton, P Worms, et al.
Advances in Biochemical Psychopharmacology|January 1, 1981
Interactions between GABA, dopamine, acetylcholine, and glutamate-containing neurons in the extrapyramidal and limbic systemsG Bartholini, B Scatton, P Worms, et al.
European Journal of Pharmacology|July 11, 1985
The effect of different types of cortical lesions on drug-induced catalepsy in rats: a pharmacological analysisP Worms, M T Willigens, D Continsouza-Blanc, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1987
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodentsP Worms, J P Kan, C G Wermuth, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1987
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibitionJ P Kan, R Steinberg, C Mouget-Goniot, et al.
Progress in Clinical and Biological Research|January 1, 1983
Indications for the use of gamma-aminobutyric acid (GABA)-agonists in convulsant disordersK G Lloyd, C Munari, P Worms, et al.
Advances in Biochemical Psychopharmacology|January 1, 1983
Neurochemical and neuropharmacological indications for the involvement of GABA and glycine receptors in neuropsychiatric disordersK G Lloyd, G DeMontis, C L Broekkamp, et al.
Drugs Under Experimental and Clinical Research|January 1, 1985
Minaprine, a new drug with antidepressant propertiesK Bizière, P Worms, J P Kan, et al.
Pageof 6